Wells Fargo keeps Amgen at equal weight; raises price target to $435
Wells Fargo maintained an equal-weight rating on Amgen and raised its price target to $435.00 per share from $400.00, according to Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.